DALLAH HEALTH

Dallah Healthcare Co.

4004StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	12.60B	12.70B	14.61B	16.78B	13.32B
Market Cap Growth	+3.3%	-13.1%	-13.0%	+26.0%	+97.1%
Enterprise Value	16.36B	16.19B	16.72B	18.80B	15.24B
Last Close Price	124.60	124.96	147.04	166.36	141.92
Valuation Multiples
Forward PE (Next 12M Est.)	18.96	21.66	28.71	41.05	42.65
PE Ratio	23.42	23.60	31.00	46.60	48.53
PEG Ratio	—	—	—	—	—
PS Ratio	3.10	3.12	4.56	5.70	5.35
PB Ratio	3.06	3.08	3.90	4.83	5.97
P/TBV Ratio	3.73	3.76	4.47	5.59	7.46
P/FCF Ratio	139.81	140.95	46.43	50.66	49.44
P/OCF Ratio	22.68	22.87	21.54	26.82	30.13
EV/Sales Ratio	4.02	3.98	5.22	6.39	6.12
EV/EBITDA Ratio	18.88	21.01	24.52	30.80	29.63
EV/EBIT Ratio	25.32	27.23	29.49	37.12	36.43
EV/FCF Ratio	181.55	179.63	53.16	56.74	56.55
Leverage & Capital
Debt / Equity Ratio	0.96	0.96	0.54	0.57	0.89
Debt / EBITDA Ratio	4.83	4.83	2.86	3.13	3.71
Debt / FCF Ratio	43.66	43.66	6.43	5.96	7.34
Net Debt / Equity Ratio	0.90	0.90	0.50	0.50	0.78
Net Debt / EBITDA Ratio	4.83	4.83	2.72	2.85	3.38
Net Debt / FCF Ratio	41.32	41.32	5.90	5.25	6.46
Efficiency & Liquidity
Asset Turnover	0.52	0.52	0.50	0.53	0.52
Inventory Turnover	8.68	8.68	8.61	8.02	6.87
Quick Ratio	0.92	0.92	0.75	0.85	1.06
Current Ratio	1.24	1.24	1.15	1.16	1.47
Returns & Yields
Return on Equity (ROE)	+13.7%	+13.7%	+13.4%	+13.5%	+13.7%
Return on Assets (ROA)	+4.7%	+4.7%	+5.5%	+5.7%	+5.5%
Return on Invested Capital (ROIC)	+7.5%	+8.7%	+10.1%	+10.6%	+9.7%
Return on Capital Employed (ROCE)	+7.9%	+7.9%	+10.7%	+10.0%	+10.4%
Earnings Yield	+4.3%	+4.2%	+3.2%	+2.1%	+2.1%
FCF Yield	+0.7%	+0.7%	+2.2%	+2.0%	+2.0%
Dividend Yield	+1.6%	+1.6%	+1.4%	+0.9%	+1.8%
Payout Ratio	+37.6%	+37.6%	+41.4%	+40.7%	+65.6%
Buyback Yield / Dilution	-3.7%	-3.7%	-0.2%	-8.2%	—
Total Shareholder Return	-2.1%	-2.1%	+1.2%	-7.3%	+1.8%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	12.60B	12.70B	14.61B	16.78B	13.32B
Market Cap Growth	+3.3%	-13.1%	-13.0%	+26.0%	+97.1%
Enterprise Value	16.36B	16.19B	16.72B	18.80B	15.24B
Last Close Price	124.60	124.96	147.04	166.36	141.92
Valuation Multiples
Forward PE (Next 12M Est.)	18.96	21.66	28.71	41.05	42.65
PE Ratio	23.42	23.60	31.00	46.60	48.53
PEG Ratio	—	—	—	—	—
PS Ratio	3.10	3.12	4.56	5.70	5.35
PB Ratio	3.06	3.08	3.90	4.83	5.97
P/TBV Ratio	3.73	3.76	4.47	5.59	7.46
P/FCF Ratio	139.81	140.95	46.43	50.66	49.44
P/OCF Ratio	22.68	22.87	21.54	26.82	30.13
EV/Sales Ratio	4.02	3.98	5.22	6.39	6.12
EV/EBITDA Ratio	18.88	21.01	24.52	30.80	29.63
EV/EBIT Ratio	25.32	27.23	29.49	37.12	36.43
EV/FCF Ratio	181.55	179.63	53.16	56.74	56.55
Leverage & Capital
Debt / Equity Ratio	0.96	0.96	0.54	0.57	0.89
Debt / EBITDA Ratio	4.83	4.83	2.86	3.13	3.71
Debt / FCF Ratio	43.66	43.66	6.43	5.96	7.34
Net Debt / Equity Ratio	0.90	0.90	0.50	0.50	0.78
Net Debt / EBITDA Ratio	4.83	4.83	2.72	2.85	3.38
Net Debt / FCF Ratio	41.32	41.32	5.90	5.25	6.46
Efficiency & Liquidity
Asset Turnover	0.52	0.52	0.50	0.53	0.52
Inventory Turnover	8.68	8.68	8.61	8.02	6.87
Quick Ratio	0.92	0.92	0.75	0.85	1.06
Current Ratio	1.24	1.24	1.15	1.16	1.47
Returns & Yields
Return on Equity (ROE)	+13.7%	+13.7%	+13.4%	+13.5%	+13.7%
Return on Assets (ROA)	+4.7%	+4.7%	+5.5%	+5.7%	+5.5%
Return on Invested Capital (ROIC)	+7.5%	+8.7%	+10.1%	+10.6%	+9.7%
Return on Capital Employed (ROCE)	+7.9%	+7.9%	+10.7%	+10.0%	+10.4%
Earnings Yield	+4.3%	+4.2%	+3.2%	+2.1%	+2.1%
FCF Yield	+0.7%	+0.7%	+2.2%	+2.0%	+2.0%
Dividend Yield	+1.6%	+1.6%	+1.4%	+0.9%	+1.8%
Payout Ratio	+37.6%	+37.6%	+41.4%	+40.7%	+65.6%
Buyback Yield / Dilution	-3.7%	-3.7%	-0.2%	-8.2%	—
Total Shareholder Return	-2.1%	-2.1%	+1.2%	-7.3%	+1.8%